ADVZ Trademark
ADVZ is a USPTO trademark filed by Mercury Pharma Group Limited. Status: Registered.
Trademark Facts
| Mark | ADVZ |
|---|---|
| Serial Number | 97342609 |
| Registration Number | 7154065 |
| Status | Registered |
| Filing Date | 2022-04-01 |
| Registration Date | 2023-09-05 |
| Mark Type | Word |
| Nice Classes | 005 (Pharmaceuticals) |
| Owner | Mercury Pharma Group Limited |
| Attorney of Record | Meghna Prasad |
| Prosecution Events | 25 |
| Latest Event | R.PR on 2023-09-05 |
Goods & Services
A full line of pharmaceuticals for the treatment of depression, hypertension, malaria, metastatic prostate cancer, benign prostatic hyperplasia, partial seizures in adults with epilepsy, attention deficit hyperactivity disorder (ADHD), heart failure in adults, heart failure in pediatric patients, atrial fibrillation in adults, edema associated with congestive heart failure, edema associated with cirrhosis of the liver, edema associated with nephrotic syndrome, steroid-induced edema, idiopathic edema, edema due to secondary hyperaldosteronism, acute enterocolitis, duodenal ulcer, and irritable bowel syndrome being irritable colon, spastic colon, mucous colitis; anti-inflammatory medicines, and immunosuppressive agents, namely, corticosteroids; pharmaceutical preparations for the treatment of cancers and abnormal cells; all of the foregoing excluding pharmaceutical preparations acting on the peripheral or central nervous system, surgical kits comprised of medical and surgical apparatus and instruments, and surgical implants comprised of human and animal tissue; all of the foregoing excluding anti-infective pharmaceutical preparations and excluding over the counter analgesic products or pain relief products